arXiv subjects

Yepeng Huang

Publications and source records attributed to Yepeng Huang.

8 recordsLinked to original sources

arXiv2026

Do LLMs Know What to Ask and When? Evaluating Multi-Turn Information Seeking

When a user question is underspecified, a capable model should recognize that its context is insufficient, identify the missing information, ask for it, and respond only once that information determines a unique answer. We formalize multi-turn information seeking as solving a k-underspecified constraint satisfaction problem, where k is the number of variables jointly required to determine the target and therefore measures the degree of missing information. We instantiate the formulation in MT-InfoSeek, a controlled evaluation suite of 5,251 problems and 9,006 task instances spanning mathematics, logic, biology, medicine, and general knowledge. We evaluate models along three axes: what they ask, when they ask it, and how the acquired information affects the final answer. Performance degrades across models and domains as underspecification increases. Models recognize that additional information is needed but underestimate how much, and in logical problems at k = 2 they under-predict the degree of missing information about four times as often as they over-predict it. They also fail to identify a minimal sufficient set of queries, improve only marginally when given the true k, and often stop before acquiring sufficient information. In tasks with ordered dependencies, an incorrect query order reduces final accuracy even when the model eventually acquires all necessary information. We measure information seeking directly through final sufficiency, which records whether the acquired information determines the target independent of answer generation. This separation shows differences between models that final accuracy alone does not capture, and indicates that the ability to seek information over multiple turns is distinct from the ability to generate answers and is not measured by current LLM evaluations.

cs.AI↗

arXiv2026

MatrAIx: Simulating the World with 8.3 Billion Persona Agents

Human evaluation of AI systems and digital products is costly, slow, and difficult to scale. Offline evaluations are more scalable but often abstract away human diversity and interactive behavior. We therefore introduce MatrAIx, a population-scale simulated-user evaluation infrastructure for testing AI systems and digital products with heterogeneous users. MatrAIx has three core components: First, Persona 8B contains 8.3 billion persona records represented by 1,290 categorical dimensions. Records are either sampled from a dependency graph that preserves correlated attributes or derived from human-authored profiles. We release a quality-filtered coreset of approximately 1 million personas, comprising 599,847 human-grounded and 400,000 synthetic records. Second, the MatrAIx Playground provides four environments in which diverse users evaluate and interact with digital products: Survey, AI Chatbot, Web, and App. Third, MatrAIx provides 1,010 application tasks spanning more than 25 domains, including Commerce, Software, Finance, and Healthcare. We conducted 18,189 evaluation trials across eight representative tasks. Persona agents were powered by three LLMs: Claude Opus 4.8, GPT 5.5, and Claude Haiku 4.5. The resulting feedback captures how decisions and preferences vary across persona backgrounds, including hesitation after a price increase, willingness to continue after an AI assistant fails, and latency tolerance. We conducted two main validation studies: First, a 400-trial controlled study evaluated persona adherence across ten behavioral attributes and all four environments. The declared behavior was expressed or correctly suppressed in 366 trials (91.5%). Second, human and LLM judges evaluated the extraction quality of human-grounded personas. Overall, MatrAIx provides an end-to-end infrastructure for evaluating AI systems and digital products with diverse simulated human users.

cs.AI↗

arXiv2025

Autonomous Agents for Scientific Discovery: Orchestrating Scientists, Language, Code, and Physics

Computing has long served as a cornerstone of scientific discovery. Recently, a paradigm shift has emerged with the rise of large language models (LLMs), introducing autonomous systems, referred to as agents, that accelerate discovery across varying levels of autonomy. These language agents provide a flexible and versatile framework that orchestrates interactions with human scientists, natural language, computer language and code, and physics. This paper presents our view and vision of LLM-based scientific agents and their growing role in transforming the scientific discovery lifecycle, from hypothesis discovery, experimental design and execution, to result analysis and refinement. We critically examine current methodologies, emphasizing key innovations, practical achievements, and outstanding limitations. Additionally, we identify open research challenges and outline promising directions for building more robust, generalizable, and adaptive scientific agents. Our analysis highlights the transformative potential of autonomous agents to accelerate scientific discovery across diverse domains.

cs.AI↗

arXiv2025

ToolUniverse: An open platform for democratizing AI scientists

AI scientists are emerging computational systems that serve as collaborative partners in discovery. These systems remain difficult to build because they are bespoke, tied to rigid workflows, and lack shared environments that unify tools, data, and analyses into a common ecosystem. We present ToolUniverse, an open platform for building AI scientists from any language or reasoning model across open- and closed-weight models. ToolUniverse standardizes how AI scientists identify and call tools through an AI-tool interaction standard, in which every tool declares its purpose in natural language, a typed schema for its inputs and outputs, and a backend-agnostic invocation format, and applies that standard to more than 2,700 scientific tools and over 130 research skills spanning machine learning models, datasets, APIs, and scientific packages for data analysis, knowledge retrieval, and experimental design. It automatically refines tool interfaces for correct use by AI scientists, generates new tools from natural language descriptions, iteratively optimizes tool specifications, and composes tools into agentic workflows. In case studies, ToolUniverse was used to create AI scientists that carried out end-to-end analyses in target assessment, chemical strategy, and clinical-trial safety. The open-source ToolUniverse is available at https://aiscientist.tools.

cs.AI↗

arXiv2025

Multimodal AI predicts clinical outcomes of drug combinations from preclinical data

Predicting clinical outcomes from preclinical data is essential for identifying safe and effective drug combinations, reducing late-stage clinical failures, and accelerating the development of precision therapies. Current AI models rely on structural or target-based features but fail to incorporate the multimodal data necessary for accurate, clinically relevant predictions. Here, we introduce Madrigal, a multimodal AI model that learns from structural, pathway, cell viability, and transcriptomic data to predict drug-combination effects across 953 clinical outcomes and 21,842 compounds, including combinations of approved drugs and novel compounds in development. Madrigal uses an attention bottleneck module to unify preclinical drug data modalities while handling missing data during training and inference, a major challenge in multimodal learning. It outperforms single-modality methods and state-of-the-art models in predicting adverse drug interactions, and ablations show both modality alignment and multimodality are necessary. It captures transporter-mediated interactions and aligns with head-to-head clinical trial differences for neutropenia, anemia, alopecia, and hypoglycemia. In type 2 diabetes and MASH, Madrigal supports polypharmacy decisions and prioritizes resmetirom among safer candidates. Extending to personalization, Madrigal improves patient-level adverse-event prediction in a longitudinal EHR cohort and an independent oncology cohort, and predicts ex vivo efficacy in primary acute myeloid leukemia samples and patient-derived xenograft models. Madrigal links preclinical multimodal readouts to safety risks of drug combinations and offers a generalizable foundation for safer combination design.

q-bio.QM↗

arXiv2025

Multimodal Medical Code Tokenizer

Foundation models trained on patient electronic health records (EHRs) require tokenizing medical data into sequences of discrete vocabulary items. Existing tokenizers treat medical codes from EHRs as isolated textual tokens. However, each medical code is defined by its textual description, its position in ontological hierarchies, and its relationships to other codes, such as disease co-occurrences and drug-treatment associations. Medical vocabularies contain more than 600,000 codes with critical information for clinical reasoning. We introduce MedTok, a multimodal medical code tokenizer that uses the text descriptions and relational context of codes. MedTok processes text using a language model encoder and encodes the relational structure with a graph encoder. It then quantizes both modalities into a unified token space, preserving modality-specific and cross-modality information. We integrate MedTok into five EHR models and evaluate it on operational and clinical tasks across in-patient and out-patient datasets, including outcome prediction, diagnosis classification, drug recommendation, and risk stratification. Swapping standard EHR tokenizers with MedTok improves AUPRC across all EHR models, by 4.10% on MIMIC-III, 4.78% on MIMIC-IV, and 11.32% on EHRShot, with the largest gains in drug recommendation. Beyond EHR modeling, we demonstrate using MedTok tokenizer with medical QA systems. Our results demonstrate the potential of MedTok as a unified tokenizer for medical codes, improving tokenization for medical foundation models.

cs.CL↗

arXiv2025

Controllable Sequence Editing for Biological and Clinical Trajectories

Conditional generation models for longitudinal sequences can produce new or modified trajectories given a conditioning input. However, they often lack control over when the condition should take effect (timing) and which variables it should influence (scope). Most methods either operate only on univariate sequences or assume that the condition alters all variables and time steps. In scientific and clinical settings, interventions instead begin at a specific moment, such as the time of drug administration or surgery, and influence only a subset of measurements while the rest of the trajectory remains unchanged. CLEF learns temporal concepts that encode how and when a condition alters future sequence evolution. These concepts allow CLEF to apply targeted edits to the affected time steps and variables while preserving the rest of the sequence. We evaluate CLEF on 8 datasets spanning cellular reprogramming, patient health, and sales, comparing against 9 state-of-the-art baselines. CLEF improves immediate sequence editing accuracy by 16.28% (MAE) on average against their non-CLEF counterparts. Unlike prior models, CLEF enables one-step conditional generation at arbitrary future times, outperforming their non-CLEF counterparts in delayed sequence editing by 26.73% (MAE) on average. We test CLEF under counterfactual inference assumptions and show up to 62.84% (MAE) improvement on zero-shot conditional generation of counterfactual trajectories. In a case study of patients with type 1 diabetes mellitus, CLEF identifies clinical interventions that generate realistic counterfactual trajectories shifted toward healthier outcomes.

cs.LG↗

arXiv2024

Empowering Biomedical Discovery with AI Agents

We envision "AI scientists" as systems capable of skeptical learning and reasoning that empower biomedical research through collaborative agents that integrate AI models and biomedical tools with experimental platforms. Rather than taking humans out of the discovery process, biomedical AI agents combine human creativity and expertise with AI's ability to analyze large datasets, navigate hypothesis spaces, and execute repetitive tasks. AI agents are poised to be proficient in various tasks, planning discovery workflows and performing self-assessment to identify and mitigate gaps in their knowledge. These agents use large language models and generative models to feature structured memory for continual learning and use machine learning tools to incorporate scientific knowledge, biological principles, and theories. AI agents can impact areas ranging from virtual cell simulation, programmable control of phenotypes, and the design of cellular circuits to developing new therapies.

cs.AI↗